Biofrontera
BFRI
14 hedge funds and large institutions have $5.29M invested in Biofrontera in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.23% more ownership
Funds ownership: 0% → 0.23% (+0.23%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
+$1.88M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$839K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$306K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$279K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$164K |
Top Sellers
BFRI Hedge Fund Activity: Q4 2021 in Review
14 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q4 2021, worth a combined $5.29M.
Buyers outnumbered sellers: 14 funds opened new BFRI positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bard Associates, opening a new position worth an estimated $1.88M.
- 14 institutional investors held Biofrontera (BFRI) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $5.29M of Biofrontera stock for Q4 2021.
- 14 funds opened new Biofrontera positions in Q4 2021 and 0 closed out, a net change of +14 holders.
- The largest Biofrontera buyer in Q4 2021 was Bard Associates, an estimated $1.88M added.
Based on aggregated 13F filings for Q4 2021.